Serina Therapeutics, Inc.
Serina Therapeutics, Inc. (SER) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 110 transactions totaling $1.7M, demonstrating a bearish sentiment with -$172.7K in net insider flow. The most recent transaction on Jan 28, 2026 involved a transaction of 6,500 shares valued at $0.
SER Insider Activity Summary
Who Is Buying SER Stock?
No significant insider buying has been recorded for SER in the recent period.
Who Is Selling SER Stock?
No significant insider selling has been recorded for SER in the recent period.
Is Serina Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SER is bearish with an Insider Alignment Score of 45/100 and a net flow of -$172.7K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SER Frequently Asked Questions
Understanding SER Insider Activity
Insider trading at Serina Therapeutics, Inc. (SER) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading SER stock, having executed 110 transactions in the past 90 days. The most active insider is Randall Moreadith (Chief Scientific Officer), who has made 81 transactions totaling $960.9K.
Related Tools
Track Serina Therapeutics, Inc. Insider Activity
Get notified when executives and directors at SER file new Form 4 transactions